ArticleJournal for immunotherapy of cancer2022

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL.

Kai Rejeski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.